Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic

被引:0
|
作者
Tai, Chi-Ming [1 ,2 ]
Bair, Ming-Jong [3 ,4 ]
Chen, Tzu-Haw [1 ]
Tseng, Cheng-Hao [5 ,6 ]
Chen, Chih-Cheng [5 ,6 ]
Lam, Hung [7 ]
Yu, Ming-Lung [8 ,9 ,10 ,11 ]
机构
[1] I Shou Univ, E Da Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Kaohsiung 824, Taiwan
[2] I Shou Univ, Coll Med, Sch Med Int Students, Kaohsiung 824, Taiwan
[3] Taitung Mackay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taitung 950408, Taiwan
[4] Mackay Med Coll, Dept Med, New Taipei 252, Taiwan
[5] I Shou Univ, E Da Canc Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Kaohsiung 824, Taiwan
[6] I Shou Univ, Coll Med, Sch Med, Kaohsiung 824, Taiwan
[7] Liouguei Dist Publ Hlth Ctr, Kaohsiung 844, Taiwan
[8] Natl Sun Yat sen Univ, Coll Med, Sch Med, Kaohsiung 804, Taiwan
[9] Natl Sun Yat sen Univ, Ctr Excellence Metab Associated Fatty Liver Dis, Kaohsiung 804, Taiwan
[10] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Dept Internal Med,Hepatobiliary Div, Kaohsiung 807, Taiwan
[11] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung 833, Taiwan
来源
VIRUSES-BASEL | 2023年 / 15卷 / 04期
关键词
direct-acting antiviral; viral hepatitis; hepatitis C; primary care; referral model; screening; elimination; VIRUS-INFECTION; ELIMINATION; CARE;
D O I
10.3390/v15040827
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Community-based screening for the hepatitis C virus (HCV) decreased during the COVID-19 pandemic. We developed a collaborative referral model between a primary clinic (Liouguei District Public Health Center, LDPHC) and a tertiary referral center to increase HCV screening and treatment uptake in a mountainous region of Taiwan. Once-in-a-lifetime hepatitis B and C screening services established by the Taiwan National Health Insurance were performed at LDPHC. Antibody-to-HCV (anti-HCV)-seropositive patients received scheduled referrals and took a shuttle bus to E-Da hospital for HCV RNA testing on their first visit. Direct-acting antiviral agents (DAAs) were prescribed for HCV-viremic patients on their second visit. From October 2020 to September 2022, of 3835 residents eligible for HCV screening in Liouguei District, 1879 (49%) received anti-HCV testing at LDPHC. The overall HCV screening coverage rate increased from 40% before referral to 69.4% after referral. Of the 79 anti-HCV-seropositive patients, 70 (88.6%) were successfully referred. Of the 38 HCV-viremic patients, 35 (92.1%) received DAA therapy, and 32 (91.4%) achieved sustained virological response. The collaborative referral model demonstrates a good model for HCV screening and access to care and treatment in a Taiwan mountainous region, even during the COVID-19 pandemic. Sustained referral is possible using this routine referral model.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Declines in Cancer Screening During COVID-19 Pandemic
    Mitchell, Edith P.
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2020, 112 (06) : 563 - 564
  • [42] Screening maternity populations during the COVID-19 pandemic
    Iida, M.
    Tanaka, M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 127 (12) : 1557 - 1557
  • [43] Social needs screening during the COVID-19 pandemic
    Mayo, Rachel
    Kliot, Tamara
    Weinstein, Rebecca
    Onigbanjo, Mutiat
    Carter, Rebecca
    CHILD CARE HEALTH AND DEVELOPMENT, 2022, 48 (06) : 935 - 941
  • [44] Cancer treatment during the COVID-19 pandemic in the Kurdistan Region of northern Iraq
    Nidhamalddin, Sara Jamil
    Hasan, Rozhan Omer
    Abubakr, Govar Othman
    ECANCERMEDICALSCIENCE, 2020, 14
  • [45] Clozapine treatment during the COVID-19 pandemic
    Dabrowska, E.
    Galinska-Skok, B.
    Zalewski, D.
    Nobis, A.
    EUROPEAN PSYCHIATRY, 2021, 64 : S669 - S670
  • [46] Cancer treatment during COVID-19 pandemic
    Jindal, Vishal
    Sahu, Kamal Kant
    Gaikazian, Susanna
    Siddiqui, Ahmad Daniyal
    Jaiyesimi, Ishmael
    MEDICAL ONCOLOGY, 2020, 37 (07)
  • [47] Stroke treatment during the COVID-19 pandemic
    Tamai, Yuta
    Arai, Noritoshi
    Fujitani, Makiko
    Kanayama, Seisaku
    Inoue, Masato
    Hara, Tetsuo
    GLOBAL HEALTH & MEDICINE, 2022, 4 (05): : 282 - 284
  • [48] Cancer treatment during COVID-19 pandemic
    Vishal Jindal
    Kamal Kant Sahu
    Susanna Gaikazian
    Ahmad Daniyal Siddiqui
    Ishmael Jaiyesimi
    Medical Oncology, 2020, 37
  • [49] Screening, Brief Intervention, and Referral to Treatment Model Based on ICD-11 Criteria of Gaming Disorder and Hazardous Gaming During the COVID-19 Pandemic
    Yen, Ju-Yu
    Higuchi, Susumu
    Ko, Chih-Hung
    Su, Shu-Fang
    CURRENT ADDICTION REPORTS, 2022, 9 (04) : 571 - 574
  • [50] Screening, Brief Intervention, and Referral to Treatment Model Based on ICD-11 Criteria of Gaming Disorder and Hazardous Gaming During the COVID-19 Pandemic
    Ju-Yu Yen
    Susumu Higuchi
    Chih-Hung Ko
    Shu-Fang Su
    Current Addiction Reports, 2022, 9 : 571 - 574